Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GeoPark LtdGPRK · Entity 5202 | Director | August 24, 2026 | August 26, 2026 |
| Science Applications International CorpSAIC · Entity 3870 | Director | April 28, 2023 | May 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GeoPark Ltd
Report date August 24, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares, par value $0.001 per shareSEC Table I · non-derivative | IndirectBy Robert A. Bedingfield Revocable Trust | 240,375 |
Reported balance
After 2026-08-24 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-24 · Grant · Acquired 5,479 · Balance 240,375 F1: Represents 2,567 fully vested shares provided as a quarterly director grant and 2,912 shares received in lieu of cash director fees. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 2,567 fully vested shares provided as a quarterly director grant and 2,912 shares received in lieu of cash director fees.
Science Applications International Corp
Report date April 28, 2023 · Filed May 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Key Executive Stock Deferral Plan | 2,943.5145 |
Reported balance
After 2023-04-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-04-28 · Grant · Acquired 10.5975 · Balance 2,943.5145 F1: Additional restricted stock units awarded upon the deemed reinvestment of dividend equivalents. |
| Common StockSEC Table I · non-derivative | Direct | 9,199.2607 |
Reported balance
Holding disclosure · report date 2023-04-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,199.2607 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 30,406 |
Reported balance
Holding disclosure · report date 2023-04-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 30,406 |
Filing footnotes · ownership attribution and instrument terms
F1: Additional restricted stock units awarded upon the deemed reinvestment of dividend equivalents.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2017 Filed Jun 8, 2017 21:01 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantStock Option (Right to Buy) · Derivative | 3,177 | $0.00 Strike: $76.34 | $0.00 |
DisclosureSEC source: 0001225208-17-011044 · doc4.xml · derivative · entry 3 BEDINGFIELD ROBERT A · CIK 0001585680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,177 Underlying: Common Stock · 3,177 shares Expires 2024-06-06 F1 · derivative.exercise_date: The option may be exercised as to 100% of the option shares on or after the earlier of: (i) the first-year anniversary of the grant date or (ii) the date the annual meeting of stockholders of the Company following the grant date is concluded. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:01 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-011044 · doc4.xml · nonDerivative · entry 1 BEDINGFIELD ROBERT A · CIK 0001585680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,685.2607 Read SEC document |
| April 28, 2017 Filed May 2, 2017 20:12 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 11.0742 | $74.17 | $821.37 |
DisclosureSEC source: 0001225208-17-008859 · doc4.xml · nonDerivative · entry 1 BEDINGFIELD ROBERT A · CIK 0001585680 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 2,660.5995 F1 · shares: Additional stock units acquired upon deemed reinvestment of dividend equivalents credited under the applicable plan. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:51 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 9.8839 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-002136 · doc4.xml · nonDerivative · entry 1 BEDINGFIELD ROBERT A · CIK 0001585680 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 2,649.5253 F1 · shares: Dividend equivalent rights. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 21:01 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 11.9598 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040938 · doc4.xml · nonDerivative · entry 1 BEDINGFIELD ROBERT A · CIK 0001585680 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 2,639.6414 F1 · shares: Dividend equivalent rights. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.